Madopar

Levodopa, the active ingredient in Madopar, is an antiparkinson agent presented as an oral tablet for oral use. It is combined with benserazide hydrochloride to treat Parkinson's disease and related Parkinsonian syndromes by improving motor function in patients. GNH USA supplies Madopar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Madopar is an antiparkinson medication that acts on the dopaminergic pathway to alleviate motor symptoms. - Parkinson's disease: improves tremor, rigidity, and bradykinesia. - Parkinsonian syndrome: reduces motor fluctuations and enhances daily functioning. - Levodopa‑responsive Parkinsonism: provides symptomatic relief of movement disorders.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Dizziness: often related to orthostatic changes. - Headache: transient and usually self‑limiting. - Orthostatic hypotension: drop in blood pressure upon standing. - Insomnia: difficulty initiating or maintaining sleep. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Dyskinesia: involuntary, erratic movements. - Hallucinations: visual or auditory disturbances. - Severe hypotension: marked blood pressure decline requiring medical attention. - Neuroleptic malignant syndrome: rare but life‑threatening reaction. - Severe depression or suicidal thoughts. - Cardiac arrhythmias: irregular heart rhythms.

Madopar requires careful clinical monitoring to ensure safe and effective use. - Dose titration: start low and adjust under medical supervision. - Monitor blood pressure: risk of orthostatic hypotension, especially in the elderly. - Assess psychiatric status: watch for hallucinations or mood changes. - Avoid abrupt discontinuation: may cause worsening of Parkinsonian symptoms. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Madopar can interact with several drug classes, requiring vigilance. Major Interactions (Avoid): - Non‑selective MAO inhibitors: may precipitate hypertensive crisis. - Antipsychotics (e.g., haloperidol): reduce levodopa efficacy. - Antihypertensive agents: may exacerbate orthostatic hypotension. Moderate Interactions (Monitor Closely): - Iron supplements: decrease levodopa absorption. - High‑protein meals: reduce bioavailability of levodopa. - Carbamazepine: may increase metabolic clearance of levodopa.